Funding competition - Biomedical catalyst 2017 round 3: early stage

06:51 EDT 7 Aug 2017 | BioNow

The aim of this competition is to support the development of technologies and processes including: disease prevention and proactive management of health and chronic conditions earlier and better detection and diagnosis of disease, leading to better patient outcomes tailored treatments that either change the underlying disease or offer potential cures The biomedical catalyst has 4 types of funding award designed to support small to medium enterprises (SMEs) that are developing a product or process. It helps them progress from initial concept through to late-stage development. Each type of award has a different scope and you should apply only if your project fits a specific competition scope. You may only submit the same application to Innovate UK twice, so it is important that you do not submit an application with an incorrect scope. This is an early-stage competition. We are looking to fund projects that enable SMEs to complete a data package sufficient to support the subsequent testing of their product or process in a clinical setting (or other relevant environment). The early-stage project can include: experimental evaluation (lab scale) use of in vitro and in vivo models (but not studies in humans or patients) to evaluate proof of concept and safety testing to appropriate regulatory standards exploration of potential production mechanisms early-stage prototyping product development planning intellectual property protection Projects should last between one and 3 years and range between £250,000 and £4 million. Competition opens: Monday 31 July 2017 Competition closes: Wednesday 11 October 2017 12:00pm For more information and details on how to apply please click here.

Original Article: Funding competition - Biomedical catalyst 2017 round 3: early stage


More From BioPortfolio on "Funding competition - Biomedical catalyst 2017 round 3: early stage"

Quick Search